1 Perivascular nerves of the sheep middle cerebral artery show immunoreactivity for both vasoactive intestinal polypeptide (VIP) and calcitonin gene-related peptide (CGRP). 2 Rings of endothelium-denuded sheep middle cerebral artery precontracted with 5-hydroxytryptamine were relaxed by CGRP (maximum relaxation = 87.8 + 8.1%, pD2 = 7.81 + 0.12, n = 12) and by VIP (maximum relaxation = 55.1 + 4.1%, pD2 = 7.65 ± 0.04, n = 18). Rings of endothelium-denuded cat middle cerebral artery precontracted with U46619 were also relaxed by vasoactive intestinal polypeptide (maximum relaxation = 53.1 + 6.1%, pD2 = 7.82 + 0.11, n = 6). 3 Haemolysate (1 pl ml-) inhibited VIP-induced relaxation in endothelium-denuded sheep and cat middle cerebral artery (n = 6) but had no effect on the CGRP-induced relaxation of the sheep middle cerebral artery (n = 6). 4 The relaxant response to VIP in endothelium-denuded sheep middle cerebral artery was inhibited by methylene blue (10pM) and augmented by either M&B 22948 (10pM) or superoxide dismutase (150 units ml-1). Indomethacin (1 uM) had no effect.
Introduction
Neuronal stimulation of the sheep middle cerebral artery results in a complex mechanical response (Duckles, 1979) , part of which is mediated by a relaxant factor that is sensitive to inhibition by haemolysate (Gaw et al., 1990) .
Immunohistochemical studies have shown the presence of both vasoactive intestinal polypeptide (VIP)-like and calcitonin gene-related peptide (CGRP)-like immunoreactivity in nerve fibres within the cerebral arteries of several species including man (Larsson et al., 1976; Edvinsson et al., 1980; Kobayashi et al., 1983; Matsuyama et al., 1983; Edvinsson & Ekman, 1984; Itakura et al., 1984; Gibbins et al., 1984; Hanko et al., 1985; Saito et al., 1985) . The relaxant effects of VIP and CGRP have been shown to be caused by a direct action on the cerebrovascular smooth muscle (Lee & Saito, 1984; Edvinsson et al., 1985; Hongo et al., 1989; Saito et al., 1989) . Although the mechanisms of action are not clear, both peptides appear to cause an increase in adenosine 3': 5'-cyclic monophosphate (cyclic AMP) levels within the muscle cells of cat cerebral arteries (Edvinsson et al., 1985) and they have been shown to hyperpolarize the smooth muscle cells of both cat and rabbit middle cerebral arteries (Saito et al., 1989; Standen et al., 1989) .
The objective of the present study was to determine whether the perivascular nerves of the sheep middle cerebral artery contained either VIP or CGRP, or both, to compare the pharmacological properties of these vasodilator peptides with the neurogenic mediator of relaxation, and to investigate whether or not the L-arginine/nitric oxide pathway is involved. ' Author for correspondence.
Methods

Preparation of specimens
Sheep heads were obtained daily from an abattoir. The brain was rapidly excised and transferred to a beaker of oxygenated physiological salt solution (composition, mM: NaCl 118.3, KCl 4.7, CaCl2 2.5, KH2PO4 1.2, MgSO4 1.2, NaHCO3 25.0 and glucose 11.1). The solution was bubbled with a 95% 02/5% CO2 gas mixture (BOC Medical Gases). The middle cerebral artery was dissected free of the brain with a short portion of the circle of Willis attached. The middle cerebral arteries from the cat were removed from the cat brain on the evening prior to the experiment and stored overnight (14-16 h) in physiological salt solution at 4°C for use the following morning.
Immunohistochemical labelling
Sheep middle cerebral arteries were cut into 4mm ring segments, slit open longitudinally and pinned flat onto pieces of Sylgard. They were fixed overnight in Zamboni's fixative (2% formaldehyde, 0.2% v/v of a 15% saturated solution of picric acid in 0.1 M phosphate buffer, pH 7.0-7.4) and then washed 3 times in 80% ethanol and 3 times in 0.1 M phosphate buffered saline, pH = 7.2. The tissue was then incubated overnight at room temperature with primary antiserum against either vasoactive intestinal polypeptide (1:400) or calcitonin generelated peptide (1:400) . After 3 washes with 1% Triton X-100 in phosphate buffered saline, all tissues were incubated for 1 h with fluorescein isothiocyanate (FITC)-conjugated goat antirabbit immunoglobulin diluted 1: 50, counterstained with pontamine sky blue to reduce background fluorescence (Cowen et al., 1985) and transferred onto clean slides. The vessels were dried, mounted with 75% (v/v) glycerol (Citifluor) in phosphate buffered saline and viewed under a Zeiss III RS fluorescence microscope fitted with the appropriate FITC filter system (excitation filter = BP 450-490, beam splitter = FT 510, barrier filter = LP 520, short pass filter = KP 560).
Antibody specificity
The specificity of immunoreactivity was determined on trial pieces of artery by preabsorbing the antibody with the appropriate antigen and then using the absorbed antibody as the 'primary antiserum' in the technique described above. No immunoreactivity was seen for either peptide after preabsorption with a 1 gm solution of the appropriate antigen.
Pharmacological studies
In these studies all middle cerebral arteries were denuded of endothelium by intraluminal perfusion with the non-ionic detergent Triton X-100 which results in denudation of the endothelium without causing any damage of the cerebrovascular smooth muscle (Connor & Feniuk, 1987) . A stainless steel cannula was inserted via the circle of Willis into the lumen of the middle cerebral artery and the tissue was perfused intraluminally with 0.1% Triton X-100 solution for 1 min at a flow rate of 0.5 ml minm-'. The tissue was then perfused with physiological salt solution for 1 min at a flow rate of 0.5mlmin-m before removing the cannula. The section of artery which had been in contact with the cannula was discarded. Rings prepared from sheep middle cerebral arteries that had not been perfused with Triton X-100 contained endothelium as demonstrated by relaxation with substance P (100 nM) following precontraction with 10PM 5-hydroxytryptamine (5-HT) (relaxation 58 + 5% of 5-HT induced tone n = 12). Triton X-100 perfusion caused complete destruction of endothelium since no relaxation occurred in any of 12 preparations on addition of substance P (100nM) following precontraction with 5-HT.
Arterial ring segments of 3-4 mm in length were cut from each middle cerebral artery. Each ring was suspended on two intraluminal parallel wires of 100pm diameter in a manner similar to that of Nielsen & Owman (1971) . The rings were then placed under 0.2 g of tension for 1 h before application of the optimal preloads for each artery, determined in preliminary experiments as 1.0g for the sheep middle cerebral artery and 0.5 g for the cat middle cerebral artery. The tissues were then left for a 30min equilibration period following which the middle cerebral arteries were precontracted with a maximal concentration of 5-hydroxytryptamine (5-HT, 10pM). Absence of functional endothelium was confirmed by lack of relaxation of the precontracted artery on addition of substance P (100nM). The tissues were washed at 0, 2, 4, 6, 8 and 10min and then left for 30min to equilibrate. The tissues were then precontracted with a submaximal concentration of 5-HT (1 pm, giving approximately 80% of 5-HT maximum contraction) and left for 5min to attain a constant tension. Either CGRP or VIP were then added to the tissue in a cumulative fashion (1 nM-300 nM) and any changes in tone were noted. The tissues were washed at 0, 2, 4, 6, 8 and 10 min and left for 30min before the addition of either haemolysate solution (1 ulml-1), L-NG monomethyl arginine (L-NMMA; 100pM) or an equivalent volume of drug vehicle as a control.
The tissues were left for a further 30 min equilibration period.
The tissues were then precontracted with 5-HT (1 pM) and the addition of either CGRP or VIP was repeated. The changes in tone induced by these agents were expressed as percentages of the resting tone induced by 5-HT (1 pM), and concentration-effect curves were plotted for each compound in the absence and presence of haemolysate or L-NMMA. In each arterial ring the potency of the agonist was calculated as the negative logarithm of the molar concentration necessary to give 50% of the maximum relaxation (pD2 value). From these individual pD2 values were calculated the mean and s.e.mean for each series of experiments. Fleming et al. (1972) showed that, generally pD2 values are normally distributed. Moreover, the statistical package that was used in the present study includes a test for normality, which confirmed a normal distribution. A recovery time of 60 min between concentration-effect curves was chosen to avoid problems of tachyphylaxis. The effect of haemolysate on the VIP-induced relaxation of the cat middle cerebral artery was investigated using a similar experimental protocol as that described above. Because of the variability of 5-HT responses in the cat middle cerebral artery, U46619 (100 nM) was used to precontract the arteries.
The effects of other agents on the VIP-induced relaxation of the sheep middle cerebral artery were examined. An identical protocol to that described above was used except that addition of the haemolysate was replaced by the addition of either indomethacin (10pM), M&B 22948 (10pM), methylene blue (1I0pM) or superoxide dismutase (150 units ml -1). The drugs were dissolved in distilled water to form a stock solution of 10mm. Exceptions to this were indomethacin and U46619 which were dissolved in 10% ethanol to give 1 mm stock solutions and M&B 22948 which was dissolved in 1 M sodium hydroxide to give a 10mM stock solution. All subsequent dilutions were carried out with 0.9% NaCl.
Haemolysate solution
The haemolysate solution was prepared by lysis of feline erythrocytes in a hypotonic phosphate buffer, followed by centrifugation and dialysis to produce a final concentration equivalent to 5% whole blood by the method of Bowman & Gillespie (1982) . The haemoglobin concentration of the haemolysate was determined by spectrophotometric analysis and it was found to be 8 + 4g I 1 (n = 3) which is equivalent to a molar concentration of 120 + 60pm. The haemolysate was used at a final bath concentration of l plml'-resulting in a haemoglobin concentration of 120 + 60 nm.
Statistical analysis
The data are expressed as the mean + s.e.mean of a group of observations; n refers to the number of heads used. Statistical comparisons between groups were made by Student's t test for paired and unpaired data. P < 0.05 was considered to be statistically significant.
Results
Immunohistochemistry
Both VIP-like and CGRP-like immunoreactivity was seen in the perivascular nerves of the sheep middle cerebral artery (Figure 1) . A dense plexus of nerves containing VIP-like immunoreactivity covered the vessel wall, mostly running longitudinally down the vessel as single varicose fibres or as small fibre bundles. The pattern formed by the nerves containing CGRP-like immunoreactivity was quite different, consisting of a complex honeycomb of fine fibres and small nerve bundles, overlayed by thick fibre bundles that were probably paravascular nerves traversing the blood vessel. Comparison of the two types of nerve plexi shows that perivascular VIPimmunoreactive nerves are more dense than CGRPimmunoreactive nerves.
Vascular relaxation
In the endothelium-denuded sheep middle cerebral artery, the contractile response elicited with 5-HT (1 ,uM) was not affected by haemolysate or any of the other agents investigated, therefore any subsequent changes in the dilator responses were not caused by changes in initial tone (Table 1 ). The potencies of CGRP and VIP in causing relaxation of the sheep middle cerebral artery were similar (pD2 = 7.81 + 0.12 for CGRP, n = 12 and 7.65 + 0.04 for VIP, n = 18) however, CGRP caused a greater maximal relaxation of the 5-HT (1 pM)- The addition of haemolysate did not inhibit the relaxation observed with CGRP (Figure 2 ), however the relaxation induced by VIP was inhibited by haemolysate and also by methylene blue, a soluble guanylate cyclase inhibitor ( Figure  3) . VIP also caused a relaxation of U46619-induced tone in the cat middle cerebral artery which was sensitive to inhibition by haemolysate (Figure 4 ). VIP had a similar potency (pD2 = 7.82 + 0.11, n = 6) and caused a similar degree of relaxation in the cat (53.1 + 6.1%, n = 6) as in the sheep middle cerebral artery.
The cyclic GMP phosphodiesterase inhibitor M&B augmented the relaxant effects of VIP ( Figure 5 ). The relaxant effect of VIP was also augmented by superoxide dismutase; however, the cyclo-oxygenase inhibitor indomethacin had no effect ( Figure 5 ).
The addition of L-NMMA did not affect either the 5-HT- 6). However, VIP-induced relaxation was inhibited by L-NMMA (100puM), which caused depression of the concentration-relaxation curve ( Figure 6 ) and inhibition, by 60 + 6%, at the highest concentration of VIP. Nerve stimulation caused relaxation to 38 + 3% of 5-HTinduced tone. This neurogenic relaxant response was significantly inhibited by L-NMMA (100pM) by 55.9 + 5.5% (n = 5) and significantly increased by superoxide dismutase (150 units ml') to 160 + 12% (n = 4).
Discussion
Both VIP and CGRP appear to be present within the perivascular nerves of the sheep middle cerebral artery and the results from the pharmacological studies have also shown that both of these agents are effective relaxant agents in the sheep middle cerebral artery. Both of these agents may therefore be regarded as potential mediators of neurogenic relaxation in the sheep cerebral vasculature. Similar results have been obtained in other species (Lee & Saito, 1984; Edvinsson et al., 1985; Saito et al., 1989) .
The VIP-induced relaxation of the sheep middle cerebral artery, like the neurogenic mediator of relaxation (Gaw et al., 1990) , was susceptible to inhibition by a haemolysate solution from feline erythrocytes. This inhibitory action of haemolysate appeared to be selective since the relaxation induced by CGRP, another vasodilator peptide, was unaffected. Methylene blue also inhibited VIP-induced relaxation. Since both haemoglobin and methylene blue inhibit the activation of soluble guanylate cyclase by nitric oxide, endothelium-derived relaxing factor (EDRF) and nitrovasodilators (Murad et al., 1978; Gruetter et al., 1981; Martin et al., 1985) it would appear that the relaxant action of VIP was mediated through a similar system to that of these agents. The inhibition of the VIP-induced relaxation of the cat middle cerebral artery by haemolysate also suggests that this mechanism is not confined to the sheep. Intracellular cyclic GMP causes relaxation by activation of protein kinases leading to dephosphorylation of the myosin light chain in the contractile apparatus and also phosphorylation of other cellular proteins (Rapoport et al., 1983) . The ability of M&B 22948, a cyclic GMP phosphodiesterase inhibitor, to augment the VIP-induced relaxation further supports the possibility that VIP may cause relaxation by an increase in cyclic GMP levels. Superoxide dismutase is known to prevent the destruction of EDRF, a free radical, by removal of the superoxide anion (Rubanyi & Vanhoutte, 1988 not mediated through EDRF since in all of these experiments the tissues had no functional endothelium. The lack of effect of indomethacin indicates that cyclo-oxygenase products were not involved in the VIP-induced relaxation and also shows that the inhibitory effect of haemolysate was not caused by inhibition of vasodilator prostaglandin synthesis as has been suggested by other authors (Toda, 1988) .
In these experiments VIP appears to have caused relaxation of the sheep cerebral artery by the production of free radicals which then activate guanylate cyclase to increase the intracellular cyclic GMP concentration resulting in smooth muscle relaxation. It is not clear from these experiments whether the VIP acts to stimulate the formation of a free radical within the arterial smooth muscle cells, to cause the release of a free radical from another cell type within the artery wall, such as macrophages, or if the VIP itself is processed to form free radicals. In the present experiments where endothelium was absent, both the VIP-induced and neurogenic relaxation of the sheep middle cerebral artery were susceptible to inhibition by L-NMMA, an inhibitor of the pathway which produces nitric oxide from L-arginine in endothelial cells and macrophages (Hibbs et al., 1987; Palmer et al., 1988) . The presence of VIP apparently stimulates the conversion of L-arginine to nitric oxide via a system which is independent of the endothelium. Recent studies in the rat anococcygeus muscle have also demonstrated a similar mechanism where the neurogenic relaxation was selectively inhibited by L-NMMA (Gillespie et al., 1989) . A recent study has reported that L-NMMA causes non-selective inhibition of vasodilators in the rat aorta by an endothelium-dependent mechanism (Thomas et al., 1989) . It is unlikely that the actions of L-NMMA described here can be ascribed to nonselective action since there was no functional endothelium in any of the tissues examined and the relaxant responses to CGRP were unaffected by L-NMMA. Immunohistochemical studies have shown a dense network of nerves containing VIP-like immunoreactivity in the sheep middle cerebral artery. It is not possible to state conclusively that VIP is the neurogenic mediator of relaxation from these studies; however, it does seem plausible since VIP is present in perivascular nerves and both VIP and the neurogenic mediator appear to act through a similar mechanism which is sensitive to both haemolysate (Gaw et al., 1990) and L-NMMA. It is not possible to rule out a minor contribution by CGRP to the neurogenic relaxant response, but any such contribution would have to be very small since CGRP is not affected by haemolysate and the CGRP innervation of the sheep middle cerebral artery is sparser than the VIP innervation. Haemolysate has been shown to inhibit the neurogenic relaxation observed in cat middle cerebral artery and other studies have also shown a reduction in the neurogenic dilator response of cat middle cerebral artery using VIP antiserum (Bevan et al., 1986) . However, it has been reported that VIP-induced relaxation of the cat middle cerebral artery was not affected by the addition of haemolysate (Lee et al., 1987) . In the present experiments, the addition of haemolysate does inhibit the ability of VIP to reduce U46619-induced tone in cat middle cerebral artery, therefore it is feasible that VIP may be the neurogenic mediator of relaxation in both the cat and sheep middle cerebral artery. If VIP acts in the human cerebral vasculature via a mechanism similar to that in the sheep then the inhibitory effects of haemolysate released from a subarachnoid blood clot could inhibit the actions of VIP. The resulting loss in vasodilator control could therefore lead to an enhancement of responses to constrictor agents resulting in vasospasm.
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